Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

UCB's anticonvulsant drug levetiracetam is safe and effective in phase III trials

Sep. 28, 1998

ZK-200775: a water-soluble AMPA antagonist with an excellent pharmacological profile

Sep. 25, 1998

Belgian academic researchers prepare bioisosteres of BM-34 as new anticonvulsants

Sep. 24, 1998

Energostim improves brain energy metabolism in infarct patients

Sep. 23, 1998

Antidepressant efficacy demonstrated with amantadine

Sep. 23, 1998

Wealth of clinical data support efficacy of ziprasidone

Sep. 23, 1998

New uses for olanzapine: psychosis in AD patients and cognition disorders in schizophrenics

Sep. 23, 1998

New phthalazine derivatives with antipsychotic-like properties

Sep. 23, 1998

Another SSRI success story: sertraline safe and effective in patients with panic disorder

Sep. 23, 1998

Sodium channel blocker with antiischemic potential emerges from Glaxo Wellcome R&D

Sep. 22, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...